- Bayer moves to block BDR's generic Nexavar in India
- Pre-emptive litigation in India: "extra-cautionary" or backdoor patent linkage?
- India rejects Bayer Nexavar CL appeal
- Indian Nexavar compulsory licence case & the 100% test
ANALYSIS Other Informa Analysis
COMMENT Other Informa Comment
JOB OF THE WEEK Promote your job vacancy